ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 102

Incorporating Temporal Artery Ultrasound in a UK District General Hospital with No Prior Colour Doppler Sonography Service: An Encouraging Preliminary Analysis

Othman Kirresh1, Chintu Gademsetty2 and Charles Li1, 1Rheumatology, NHS Royal Surrey County Hospital, Surrey, United Kingdom, 2Radiology, NHS Royal Surrey County Hospital, Surrey, United Kingdom

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: biopsies, large vessel vasculitis, quality improvement, temporal arteritis and ultrasonography

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Education Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Temporal Arteritis (TA) is the most common large vessel vasculitis, affecting adults over the age of 50. It is associated with significant morbidity due to ischemic manifestations such as blindness and stroke.1 The gold standard for diagnosis has always been temporal artery biopsy (TAB) and although highly specific (98%) it lacks sensitivity, and can yield false-negative results in up to 60% of cases. The emergence of CDS in the diagnosis of GCA has now been widely acknowledged, further supported by meta-analyses confirming its validity.2 Prospective postulate a better sensitivity compared to TAB.3 For hospitals with no prior experience in TA-CDS a common validity concern lies in the procedures intra-operator reliability.

Methods:

A temporal arteritis (TA) pathway incorporating CDS was introduced into a small UK district general hospital serving a population of 200,000. It was presented at a local hospital medical meeting attended by all doctors to raise awareness. Subsequently the pro forma was distributed throughout the trust including medical wards, Accident and Emergency (A&E) and the Medical assessment unit (MAU). 

As part of the pathway every patient who was referred for a TAB (performed by the Maxillofacial surgeons), also underwent a CDS. The latter was performed by one musculoskeletal (MSK) Consultant Radiologist who was blinded in terms of patient symptoms i.e. side of headache. Crucially the radiologist although experienced (n= 20,000 MSK Ultrasound studies) has not been trained specifically in temporal artery ultrasound. Patients would then be followed up in Rheumatology Outpatients with the results of the investigations within 4 weeks.

Results:

Table 1:

Referrals

N= 20

Treated for TA

13/20

Gender

Male:      10/20

Female: 10/20

Age Range

56- 85

Mean Age

71

Mean time prior to TAB on GC

10.2 Days

Range: 48 hours – 17 days

Mean time prior to CDS on GC

5.1 Days

Range: 24 hours – 11 days

Mean duration of GC Neg for TA

5.7 weeks

Average initial GC dosage

42.3mg

Range: 40 – 60 mg

TAB positive

TAB Negative

CDS Positive

3/12  (3/13)

7/20 (7/13)

CDS Negative

0/20 (0/13)

2/20 (2/13)

Positive TAB

3/20   (3/13)

Positive CDS

11/20 (11/13)

McNemar Test (CDS vs TAB)

P = 0.023

TAB had a specificity of 100% in contrast the sensitivity was 23% (Sensitivity 84% for CDS).

Conclusion:

TA can be a challenging diagnosis for clinicians to make; hence diagnostic investigations are important. Our results demonstrate the critical role and value of CDS in the diagnosis and management of TA. When clinical suspicion is high for TA our data shows CDS as specific as TAB, but more importantly even when a radiologist is new to the procedure significantly higher sensitivity when compared to TAB (84%, P<0.023). Despite non familiarity of the operator the procedure adds to the diagnostic process. Our study data is line with existing data, 2,3 and highlights the necessity to incorporate CDS in the diagnosis of TA.

References

1.Jennette JC, Falk RJ, Bacon PA et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013;65:1-11

2. Karassa FB, Matsagas MI, Schmidt WA et al. Meta-ana– lysis: test performance of ultrasonography for giant-cell arteritis. Ann Intern Med 2005;142:359-69.

3. Luqmani R, Lee E, Singh S, Gillett M et al (2016). The role of Ultrasound Compared to biopsy of Temporal Arteries in the Diagnosis and Treatment of Giant Cell Arteritis


Disclosure: O. Kirresh, None; C. Gademsetty, None; C. Li, None.

To cite this abstract in AMA style:

Kirresh O, Gademsetty C, Li C. Incorporating Temporal Artery Ultrasound in a UK District General Hospital with No Prior Colour Doppler Sonography Service: An Encouraging Preliminary Analysis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/incorporating-temporal-artery-ultrasound-in-a-uk-district-general-hospital-with-no-prior-colour-doppler-sonography-service-an-encouraging-preliminary-analysis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/incorporating-temporal-artery-ultrasound-in-a-uk-district-general-hospital-with-no-prior-colour-doppler-sonography-service-an-encouraging-preliminary-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology